Table 2 Pre- and post-treatment SUVmax and ΔSUVmax values compared to morphovolumetric tumor response assessed by RECIST
Patient | Target lesion | SUVmax prea | SUVmax postb | ΔSUVmax c (%) | RECISTd |
|---|---|---|---|---|---|
1 | Mediastinal mass | 10.00 | 7.50 | −25 | PR |
2 | Mediastinal mass | 6.60 | 3.50 | −47 | PR |
3 | Mediastinal mass | 13.00 | 6.20 | −52 | SD |
4 | Pleural implant | 9.23 | 0.00 | −100 | CR |
5 | Mediastinal mass | 4.10 | 3.00 | −27 | PR |
6 | Lung lesion | 18.70 | 17.00 | −9 | SD |
7 | Lymph node | 12.00 | 11.50 | −4 | SD |
8 | Pleural implant | 5.80 | 2.10 | −64 | PR |
9 | Pleural implant | 7.60 | 1.70 | −78 | PR |
10 | Lymph node | 3.70 | 8.20 | 120 | PD |
11 | Mediastinal mass | 4.19 | 5.30 | 26 | SD |
12 | Mediastinal mass | 8.40 | 11.30 | 35 | SD |
13 | Lung lesion | 19.70 | 5.70 | −71 | PR |
14 | Mediastinal mass | 4.20 | 4.60 | 10 | PR |
15 | Mediastinal mass | 5.00 | 3.00 | −40 | PR |
16 | Mediastinal mass | 8.40 | 0.00 | −100 | CR |
17 | Pleural implant | 4.00 | 4.80 | 20 | PD |
18 | Mediastinal mass | 15.60 | 18.5 | 19 | PR |
19 | Mediastinal mass | 7.70 | 2.20 | −71 | PR |
20 | Lung lesion | 8.80 | 14.40 | 64 | SD |
21 | Mediastinal mass | 8.30 | 5.70 | −31 | PR |
22 | Lymph node | 8.50 | 5.40 | −36 | PR |
23 | Pleural implant | 3.30 | 1.90 | −42 | PR |
24 | Mediastinal mass | 7.00 | 4.50 | −36 | SD |
25 | Mediastinal mass | 5.60 | 1.80 | −68 | PR |
26 | Mediastinal mass | 20.00 | 15.00 | −25 | PR |
27 | Mediastinal mass | 4.80 | 6.70 | 40 | SD |